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1. In~odu~tio~ 
.5-Methyltetrahydrofolate (m thyl-FH4 j has been 
reported to be the methyl donor in the enzymic 
N-methylation of biogenic amines in several tissues 
[l-5] , However a more rigorous analysis of the 
reaction has shown that N-methylation does not 
occur and that the transfer of one-carbon groups to 
biogenic amines from methyl-FH, results in the 
formation of alicyclic alkaloids [6--81. These results 
have been interpreted in terms of an enzyme that 
cleaves methyl-FHe to produce FH4 and formalde- 
hyde, the latter subsequently reacting non-enzymically 
with the amines to produce alkaloids in a Pictet- 
Spengler condensation [9-l I]. Our investigations 
into the mechanism of this reaction led us to the 
conclusion that the enzyme responsible for the 
transfer of one-carbon units from methyl-FH4 to 
biogenic arnines may be 5,10-methylene-FH4 
reductase (EC 1.1.1.68) [121. A consequence of this 
mechanism is that methylene-FH,, formed enzymically, 
is an intermediate in the transfer of the one-carbon 
unit (fig.la). 
If this hypothesis i  correct, then other reactions 
generating methylene-FH4 should be capable of 
mediating in the synthesis of alicyclic alkaloids from 
biogenic amines. One such enzyme is serine hydroxy- 
methyltransferase (EC 2.1.2.1), which catalyses the 
reaction shown in fig.lb. Here we have tested the 
ability of serine hydroxymethyltransferase to transfer 
Address correspondence to: A. J. T. 
* Present address: Department of Biochemistry, University 
of the West Indies, Mona, Kingston 7, Jamaica 
the &carbon atom of serine to the biogenic amine 
tryptamine, with the resultant formation of the 
alkaloid 1,2,3,4-tetrahydro-fl-carboline (f g. 1). 
2. Materials and methods 
Serine hydroxymethyltransferase was purified 
from ox liver by the method in [ 131, and shown to 
possess no detectable methylene-FHe reductase 
activity. Methylene-FH~ reductase was purified from 
pig liver as in [12] , 1,2,3,4-Tetr~ydro-~-c~bo~e 
hydrochloride was synthesised by the method in [ 143. 
The melting point and infrared spectra of the product 
were in agreement with data in [8,1 I]. Mass spectral 
analysis of the product showed a molecular ion at 
172 amu, the base peak at 143 amu (loss of CH2NH) 
and a fragment ion at 115 amu (indole nucleus) in 
agreement with (81. Allother chemicals and materials 
were obtained from standard commercial sources. 
Serine hydroxymethyltr~sferase (0.05 units) was 
incubated in 0.5 ml total volume with the following 
components: 30 gmol potassium phosphate buffer 
(pH 7,4), 0.1 pmol pyridoxal5’-phosphate, 0.1 @no1 
(0.5 &i) L[3-14C]serine, 0.8 pmol FH,, 4 i.tmol 
2-mercaptoethanol and 10 pmol tryptamine hydro- 
chloride. Blank incubations were performed both in 
the absence of FHq, and with enzyme that had been 
boiled for 5 min. The conditions of the incubations 
were essentially those used in the routine assay of 
serine hydroxymethyltransferase ctivity [ li] . 
Methylene-FH4 reductase (0.04 units) was incu- 
bated in 0.6 ml total volume with the following com- 
ponents: 100 Fmoi potassium phosphate hrt ftt*l 
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(pH 6.3), 0.33 pm01 (0.5 tzCi) 5-[14C]methyl-FH4, 
1.2 nmol FAD, 1 .O gmol EDTA, 4.8 pmol ascorbate, 
0.3 pmol menadione(2-me~yl-1,4-naphthoqu~one) 
and 10 I.tmol tryptamine hydroc~oride. Blank incuba- 
tions were performed with enzyme that had been 
boiled for 5 min. The conditions of the incubations 
were essentially those used in the routine assay of this 
enzyme [ 161. 
All incubations were performed at 30°C for 
30 min. The reactions were then stopped by the addi- 
tion of 1 .O ml 0.6 M borate buffer, pH 10, and to 
each tube was added 10 pm01 of either Nw-methyl- 
trypt~~e or 1,2,3,4-tetr~ydro-~-~arbol~e hydro- 
chloride. The products were extracted into toluene, 
evaporated to dryness and the residues taken up in 
acetone. Samples from each incubation were applied 
to a silica-gel thin-layer plate (Merck F254) which 
was developed in butan-1-al/acetic a id/H?0 
(60 : 30 : 10, by vol.), dried and sprayed with a 
solution of p-dimethylaminocinnamaldehyde to 
visualise the products. The respective product zones 
were scraped from the plate and their radioactivity 
determined. 
3. Results and discussion 
Methylene-FH, reductase was shown to mediate 
in the formation of tetrahydro-@carbole from 
tryptamine and methyl FH4 (table I), in agreement 
with the conclusions of other groups [6,8,10]. The 
probable mechanism of this one-carbon transfer 
Fig.1. Proposed role of 5,10-methylenetetrahydrofolate in 
the transfer of one-carbon groups to biogenic ammes. The 
enzymes involved are: (a) methylenetetrahydrofolate 
reductase (EC 1 .l .1.68) and (b) serine hydroxymethyl- 
transferase (EC! 2.1.2.1). The condensation to form tetra- 
hydro~-~bol~e (reaction c) is presumed to be non- 
enzymic. 
process has been described in [ 121 and is summarized 
in fig.1. The results reported here (table 1) demon- 
strate that serine hydroxymethyltransferase can
transfer the P-carbon atom of serine to tryptamine in 
Table 1 
Thin layer chromatography of the products of the incubation of serine 
hydroxymethyltransfera~ and methylene-FH~ reductase with tryptamine 
Radioactivity recovered 
Enzyme incubation conditions from product zone (dpm) 
THBC NMT 
Serine hydroxymethyltransferase 1500 360 
Serine hydroxymethyltransferase (boiled) 200 20 
Serine hydroxymethyltransferase (-FH,) 130 - 
Methylene-FH, reductase 600 20 
Methylene-FH, reductase (boiled) 20 
The experimental conditions are as described in the text 
~~&~e~~fjo~s~ THBC, Te~~y~o~-~bo~e; NMT, ~~-methyl~yptam~e 
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a reaction dependent upon the presence of FH4 
which would further substantiate the proposed 
mechanism for /3-carboline synthesis. A small amount 
of radioactivity was apparently isographic with the 
methyltryptamine as reported [lo] , but the major 
product wasisographic with the /3-carboline. No radio- 
activity was recovered from the product zones if the 
incubations were carried out in the absence of 
tryptamine. The difficulty encountered in separating 
the N-methyl amine from the cyclised amine led to 
the original confusion as to the nature of the product 
found [6-81. Several different solvent systems were 
used in an attempt to increase the resolution on the 
chromatogram, and the one chosen afforded the best 
separation of those tested. I+ is at present unclear 
why the proportion of radioactivity apparently iso- 
graphic with the methyltryptamine is greater when 
serine hydroxymethyltransferase is used, although 
this may well be a reflection of the different incuba- 
tion conditions required for the two enzymes. The 
major product in both cases was clearly the fl-carboline. 
Thus two enzymes, serine hydroxymethyltrans- 
ferase and methylene-FH4 reductase, each capable 
of generating methylene-FH,, can mediate in the 
transfer of one-carbon units to biogenic amines 
in vitro producing alicyclic alkaloids. There has been 
considerable speculation in the literature concerning 
the possible formation of such compounds in vivo 
[ 17-201 since they are capable of inhibiting mono- 
amine oxidase activity as well as the high-affinity 
uptake of amine neurotransmitters [21-251. It is 
unlikely that methylene-FH, reductase mediates 
in the synthesis of P-carboline alkaloids in vivo, 
since this enzyme appears to function almost 
exclusively in the direction of methyLFH4 syn- 
thesis under physiological conditions [ 161. However, 
serine hydroxymethyltransferase catalyses a readily 
reversible reaction and may be capable of participat- 
ing in fl-carboline synthesis in vivo in brain regions 
where indoleamine or catecholamine concentrations 
are high. In view of the pharmacological effects of 
these alkaloids, their possible formation in brain 
would merit further investigation. 
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